XtalPi Holdings Limited Announces Major Turnaround: First Full-Year Profit Expected for FY2025

Key Highlights of the Announcement

• First Full-Year Profit: XtalPi Holdings Limited expects to report a profit after taxation and a profit attributable to equity holders of not less than RMB100 million for the year ended 31 December 2025 (FY2025). This marks the company’s first ever full-year profit.
• Significant Turnaround: This result represents a dramatic turnaround from FY2024, during which the company recorded a net loss after taxation of approximately RMB1,514.9 million and a loss attributable to equity holders of approximately RMB1,516.6 million.
• Revenue Surge: The group anticipates a substantial increase in revenue, reaching at least RMB780 million for FY2025. This is an approximate 193% increase compared to the RMB266.4 million revenue recorded in FY2024.
• Core Business Improvement: The narrowing of losses from the group’s core businesses, namely intelligent robotics solutions and drug discovery solutions, has contributed significantly to the turnaround.
• Financial Asset Gains: Net fair value gains on financial assets measured at fair value through profit or loss (FVTPL) are expected to soar to not less than RMB500 million in FY2025. This is an increase of approximately 1,876% from the RMB25.3 million recorded in FY2024.
• Absence of Preferred Share Losses: The company will not record any fair value losses on convertible redeemable preferred shares (CRPS) in FY2025. In FY2024, these losses amounted to RMB875.4 million. All CRPS were automatically converted to ordinary shares upon the company’s listing on the Hong Kong Stock Exchange in FY2024, eliminating further gains or losses from valuation changes of these instruments going forward.

Important Information for Shareholders and Investors

• Potential Share Price Impact: The announcement is highly price-sensitive. The transition from a significant net loss to the company’s first full-year profit, combined with strong revenue growth and financial asset gains, is likely to materially impact investor sentiment and the company’s share price.
• Caution Advised: The results are based on preliminary management accounts and available information. These figures are unaudited and subject to finalisation and possible adjustments. Actual results may differ, and shareholders should await the official audited annual results for FY2025.
• Absence of CRPS Losses: The removal of CRPS-related losses is a one-off benefit following the completion of the company’s public listing. Shareholders should note that this factor may not recur in future years.
• Timing of Official Results: The audited annual results for FY2025 will be published in accordance with Hong Kong Stock Exchange requirements. Investors should monitor the official release for confirmed figures and further details.
• Board Composition: As of 3 March 2026, the Board consists of Dr. Wen Shuhao (Chairman and Executive Director), Dr. Ma Jian, Dr. Lai Lipeng, Dr. Jiang Yide Alan (Executive Directors), and Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki, Mr. Chow Ming Sang (Independent Non-Executive Directors).

Detailed Financial Breakdown

• FY2024:
  • Net loss after taxation: RMB1,514.9 million
  • Loss attributable to equity holders: RMB1,516.6 million
  • Revenue: RMB266.4 million
  • Net fair value gains on financial assets (FVTPL): RMB25.3 million
  • Fair value loss on CRPS: RMB875.4 million
• FY2025 (Expected):
  • Net profit after taxation: Not less than RMB100 million
  • Profit attributable to equity holders: Not less than RMB100 million
  • Revenue: Not less than RMB780 million
  • Net fair value gains on financial assets (FVTPL): Not less than RMB500 million
  • Fair value loss on CRPS: None

Investor Guidance

Shareholders and potential investors are strongly advised to exercise caution when trading the company’s shares. The preliminary nature of the financial data means that there could be variations in the final, audited numbers. Investors should closely monitor future announcements and the official release of the FY2025 annual results for the most accurate and reliable information.

Conclusion

The expected turnaround in XtalPi Holdings Limited’s financial performance, driven by robust revenue growth, a surge in financial asset gains, and the elimination of CRPS-related losses, marks a pivotal moment for the company. This development is likely to be of significant interest to shareholders and could have a material impact on the company’s share price. The company’s management and board have emphasised caution and the importance of reviewing the final audited results before making any investment decisions.

Disclaimer: This article is based on preliminary unaudited management accounts and information provided in the company’s public announcement. Actual financial results may differ. This is not investment advice. Investors are urged to await the official audited results and seek professional guidance before making investment decisions.

View XTALPI Historical chart here